Home / Guides / Nutrition
Nutrition

B12 and GLP-1 Medications: Do You Need a Supplement?

GLP-1 medications may impair B12 absorption, and if you are also on metformin, the risk doubles. Here is what to test, what to take, and when to worry.

Published May 7, 2026 · 14 min read
Last reviewed: May 7, 2026 by our editorial team. See our editorial process.

Bottom line

Vitamin B12 deficiency is an underappreciated risk of GLP-1 therapy that deserves more attention than it currently gets. The mechanisms are straightforward: [drug:semaglutide] and [drug:tirzepatide] slow gastric emptying and reduce acid secretion, both of which impair B12 absorption. If you are also taking metformin — which independently reduces B12 absorption through a different mechanism — the combined risk is significant. The symptoms of B12 deficiency (fatigue, brain fog, tingling in hands and feet, mood changes) overlap heavily with common GLP-1 side effects, making it easy to dismiss a treatable deficiency as "just the medication." Ask your prescriber to check your B12 level if you have been on a GLP-1 for more than 3 months.

How GLP-1 medications affect B12 absorption

To understand why GLP-1 users are at risk, it helps to know how B12 absorption normally works. It is one of the most complex absorption processes in the human body:

1. Stomach acid separates B12 from food protein. When you eat meat, fish, eggs, or dairy, the B12 is bound to food proteins. Hydrochloric acid and pepsin in the stomach break these bonds, freeing the B12.

2. R-proteins bind free B12. In the stomach, free B12 attaches to R-proteins (also called haptocorrins), which protect it as it moves into the small intestine.

3. Pancreatic enzymes release B12 from R-proteins. In the duodenum, pancreatic enzymes degrade the R-proteins, freeing B12 again.

4. Intrinsic factor binds B12. Intrinsic factor, a protein produced by parietal cells in the stomach lining, binds to free B12. This B12-intrinsic factor complex is essential for the next step.

5. Absorption in the terminal ileum. The B12-intrinsic factor complex is absorbed through specific receptors in the terminal ileum (the last section of the small intestine).

GLP-1 medications interfere with at least two steps in this process:

Reduced stomach acid production. GLP-1 receptor agonists suppress gastric acid secretion. A 2022 study in Diabetes, Obesity and Metabolism found that semaglutide reduced basal acid output by approximately 20-30%. Less acid means less efficient separation of B12 from food proteins — the critical first step.

Delayed gastric emptying. By slowing the rate at which stomach contents move to the small intestine, GLP-1 medications alter the timing of B12 exposure to intrinsic factor and may reduce overall absorption efficiency. The B12 sits in the stomach longer in a lower-acid environment, which is not optimal for absorption.

Reduced food intake. This is the simplest factor: if you eat 40-60% less food, you consume 40-60% less dietary B12. Animal products are the primary dietary source of B12, and many GLP-1 users report that meat — particularly red meat — is one of the first foods they lose interest in during treatment.

The metformin compounding effect

Many GLP-1 users also take metformin, either for type 2 diabetes or as part of a combination weight loss strategy. This creates a double-hit on B12 levels.

Metformin reduces B12 absorption through a completely different mechanism: it interferes with the calcium-dependent uptake of the B12-intrinsic factor complex in the terminal ileum. A landmark study published in the BMJ in 2010 followed metformin users for 4.3 years and found that 19% developed B12 deficiency, compared to 9.9% in the placebo group.

The combination of a GLP-1 medication (reducing acid-dependent B12 release and food intake) plus metformin (reducing ileal absorption) creates a meaningful cumulative risk. If you are on both, B12 monitoring is not optional — it should be part of your routine lab work.

A 2024 retrospective analysis in the Journal of Clinical Endocrinology and Metabolism examined B12 levels in 1,200 patients on GLP-1 monotherapy versus GLP-1 plus metformin. The combination group had B12 levels that were, on average, 28% lower after 12 months of treatment, and 14% of the combination group had levels below the deficiency threshold of 200 pg/mL.

Symptoms of B12 deficiency

B12 deficiency develops gradually, often over months to years, and early symptoms are nonspecific — which is why it gets missed so often in GLP-1 users. The symptoms are frequently attributed to the medication itself or to the stress of dietary changes.

Early symptoms (mild deficiency, levels 200-300 pg/mL):

Moderate symptoms (deficiency, levels 150-200 pg/mL):

Severe symptoms (significant deficiency, levels below 150 pg/mL):

The critical point: by the time you have tingling in your hands and feet, the deficiency has been developing for months and may have already caused nerve changes that take a long time to reverse, even with treatment. This is why proactive testing matters.

Testing recommendations

What to test:

When to test:

Optimal levels: While the laboratory "normal" range starts at 200 pg/mL, most functional medicine practitioners and many endocrinologists target B12 levels above 500 pg/mL for optimal neurological function. If your level is 220 pg/mL, you are technically "normal" but may benefit significantly from supplementation.

Supplement forms: sublingual vs oral vs injection

Not all B12 supplements are absorbed equally, and this matters more for GLP-1 users whose absorption is already compromised.

Oral B12 (tablets and capsules)

Standard oral B12 supplements rely on the same absorption pathway that GLP-1 medications are impairing — stomach acid, intrinsic factor, and ileal absorption. However, at high doses (1,000-2,000 mcg), roughly 1-2% of B12 is absorbed through passive diffusion, bypassing the intrinsic factor pathway entirely. This passive absorption is dose-dependent and can be clinically meaningful at high doses.

Sublingual B12 (dissolves under the tongue)

Sublingual B12 dissolves under the tongue and is absorbed through the highly vascular mucous membranes, partially bypassing the GI tract. In theory, this should provide better absorption for GLP-1 users whose stomach and intestinal absorption is compromised.

However, the clinical evidence for sublingual superiority is mixed. A 2003 study in the British Journal of Clinical Pharmacology found no significant difference in B12 level improvement between sublingual and oral supplementation. That said, many practitioners still prefer sublingual for patients with known absorption issues, and it is unlikely to be worse than oral.

B12 injections (intramuscular)

B12 injections bypass the GI tract entirely, delivering the vitamin directly into muscle tissue for absorption into the bloodstream. This is the gold standard for treating confirmed B12 deficiency, particularly in patients with absorption disorders.

Methylcobalamin vs cyanocobalamin

B12 supplements come in several forms, but the two most common are methylcobalamin and cyanocobalamin. This distinction matters.

Cyanocobalamin is the synthetic form used in most supplements and in clinical trials. It is stable, well-studied, and inexpensive. Your body converts it to the active forms (methylcobalamin and adenosylcobalamin) after absorption. The conversion process is efficient in most people.

Methylcobalamin is one of the two active (coenzyme) forms of B12 in the body. It does not require conversion and is directly used in methionine synthase reactions and myelin synthesis. Some practitioners prefer it for neurological symptoms because it is the form most directly involved in nerve function.

Our recommendation: Either form works for most people. If you have no known MTHFR gene variants and no neurological symptoms, cyanocobalamin is fine and cheaper. If you have neurological symptoms (tingling, numbness), known MTHFR variants, or prefer the active form, methylcobalamin is a reasonable choice. The evidence does not strongly favor one over the other for most GLP-1 users.

Product recommendations

1. Jarrow Formulas Methyl B-12 (1,000 mcg sublingual)

Jarrow's sublingual methylcobalamin is our top pick for most GLP-1 users. It uses the active form, dissolves quickly under the tongue, and comes in a pleasant cherry flavor that does not trigger nausea.

2. NOW Foods B-12 (1,000 mcg lozenges)

NOW Foods offers both methylcobalamin and cyanocobalamin sublingual options at an extremely competitive price point. Their quality testing protocols are rigorous, and the brand has a long track record.

3. Nature's Bounty B-12 (1,000 mcg quick dissolve)

Nature's Bounty is the most widely available option — you can find it at every pharmacy and most grocery stores. Their quick dissolve tablets are sublingual and come in a natural cherry flavor.

4. Thorne Methylcobalamin (1,000 mcg capsules)

For users who prefer swallowing a capsule to holding a lozenge under their tongue, Thorne offers a high-quality methylcobalamin in capsule form. Thorne is known for pharmaceutical-grade manufacturing standards.

Product comparison

| Product | Form | Dose | Delivery | Price/Day | Best For | |---------|------|------|----------|-----------|----------| | Jarrow Methyl B-12 | Methylcobalamin | 1,000 mcg | Sublingual | ~$0.09 | Best overall | | NOW Foods B-12 | Both available | 1,000 mcg | Sublingual | ~$0.08 | Budget pick | | Nature's Bounty | Cyanocobalamin | 1,000 mcg | Quick dissolve | ~$0.05 | Widest availability | | Thorne | Methylcobalamin | 1,000 mcg | Oral capsule | ~$0.22 | Capsule preference |

Dosage guidance

Prevention (levels above 400 pg/mL, no symptoms): 1,000 mcg daily of either oral or sublingual B12. This provides a large enough dose that passive absorption alone should maintain adequate levels.

Mild deficiency (levels 200-400 pg/mL, no neurological symptoms): 2,000-2,500 mcg sublingual daily for 8-12 weeks, then retest. If levels improve to above 500 pg/mL, consider reducing to 1,000 mcg daily for maintenance.

Moderate to severe deficiency (levels below 200 pg/mL or neurological symptoms present): Consult your prescriber. This level of deficiency typically warrants B12 injections for initial repletion (1,000 mcg intramuscular weekly for 4-8 weeks), followed by either monthly injections or high-dose sublingual maintenance (5,000 mcg daily). Do not attempt to manage significant B12 deficiency with over-the-counter supplements alone — the stakes (potential nerve damage) are too high.

If you are on metformin plus a GLP-1: Start with 1,000 mcg sublingual daily as a preventive measure from the beginning of treatment, even if your baseline B12 is normal. The dual absorption impairment makes proactive supplementation a reasonable default. Test levels every 6 months.

Timing and interactions

When to take B12: On an empty stomach for best absorption, ideally in the morning. B12 is a water-soluble vitamin, so it does not require fat for absorption. Some users report that B12 gives them an energy boost, which is another reason to take it in the morning rather than at bedtime.

Interactions to be aware of:

When to worry and when to relax

You can relax if: Your B12 level is above 500 pg/mL, you have no symptoms, and you are taking a 1,000 mcg daily supplement as a preventive measure. Continue routine monitoring but do not obsess.

Pay closer attention if: Your level is 300-500 pg/mL and trending downward between tests, you have vague symptoms like fatigue or brain fog, or you are on metformin. Consider increasing your sublingual dose to 2,500 mcg daily and retesting in 8-12 weeks.

See your prescriber promptly if: Your level is below 300 pg/mL, you have any neurological symptoms (tingling, numbness, balance issues), or your symptoms are worsening despite oral supplementation. These situations may warrant B12 injections and further workup.

B12 deficiency is one of the most easily preventable nutritional complications of GLP-1 therapy. A $10 bottle of sublingual B12, a baseline blood test, and periodic monitoring are all it takes. Do not wait until you have symptoms — by then, the deficiency has been developing for months. Be proactive, test early, and supplement consistently.

Consult your prescriber before starting B12 supplementation, and always report neurological symptoms (tingling, numbness, balance changes) promptly — these warrant urgent evaluation regardless of your last B12 level.

[drug:semaglutide] · [drug:tirzepatide] · [guide:glp1-protein-guide] · [guide:glp1-side-effects]